Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9HR8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,868
Award facts
- Contract value 100% obligated
- $19,867.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $19,867.77. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp's federal contracting portfolio demonstrates extensive experience supplying pharmaceutical products and medical supplies to military and veteran healthcare systems across multiple therapeutic domains. The parent IDC enables the company to deliver critical medical commodities, including specialty medications, brand-name and generic drugs, and vaccines to support Defense Health Agency operations and other government healthcare customers globally. The firm fixed-price delivery order structure and competitive award basis reflect AmerisourceBergen's capability to meet federal procurement requirements while supporting the Defense Logistics Agency's mission to supply the military healthcare supply chain efficiently.
Quick answers
Who was awarded contract SPE2DR26F9HR8?
SPE2DR26F9HR8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9HR8 worth?
The government has obligated $19,868 on SPE2DR26F9HR8.
Is contract SPE2DR26F9HR8 an order under another contract?
Yes. SPE2DR26F9HR8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HR8 competed?
The extent of competition for SPE2DR26F9HR8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award